AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption – Hagens Berman
SAN FRANCISCO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- AstraZeneca, the British-Swedish pharmaceutical giant, is facing a securities class action lawsuit in the U.S. alleging the company misled investors about its business practices in China, a critical market …